- Efficacy and Safety of Adalimumab in Moderately to Severely Active Cases of Ulcerative Colitis: A Meta-Analysis of Published Placebo-Controlled Trials
-
Zhang ZM, Li W, Jiang XL
- KMID: 2363972
- Gut Liver.
- 2016 Mar;10(2):262-274.
- doi: 10.5009/gnl15042
BACKGROUND/AIMS: To evaluate the efficacy and safety of adalimumab (ADA) in moderately to severely active ulcerative colitis (UC) patients who are unresponsive to traditional therapy. METHODS: Electronic databases, including the PubMed,... -
- CITED
-
- Close
- SHARE
-
- Close
